Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

SGX/AP4 stock hub

SGX/AP4 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SGX/AP4is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Singapore Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SGX/AP4

In the news

Latest news · SGX/AP4

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.2

P25 n/aP50 n/aP75 n/a

Trailing P/E18.5

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC22.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SGX/AP4 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

MYR

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Singapore
Country code	SG
Employees	3,000
Enterprise value	SGD 932.8M
Exchange	Singapore Exchange
Financial currency	MYR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	SG1U22933048
Last refreshed	2026-05-10
Market cap	SGD 1.1B
Price	SGD 0.77
Price currency	SGD
Rev Per Employee	101,576x
Sector	Healthcare
Sic	3842
Symbol	sgx/AP4
Website	https://www.riverstone.com.my

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.4%
EV Earnings	15.23x
EV/EBIT	13.07x
EV/EBITDA	9.87x
EV/Sales	3.06x
Forward P/E	18.18x
P/B ratio	2.41x
P/E ratio	18.51x
P/S ratio	3.72x
PE Ratio10 Y	14.76x
PE Ratio3 Y	16.23x
PE Ratio5 Y	11.76x
PEG ratio	2.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.42%
EBITDA Margin	30.85%
Gross margin	29.09%
Gross Profit	SGD 88.6M
Gross Profit Growth	-23.43%
Gross Profit Growth Q	-17.32%
Gross Profit Growth3 Y	-12.79%
Gross Profit Growth5 Y	-19.75%
Net Income	SGD 61.3M
Net Income Growth	-27.59%
Net Income Growth Q	-22.97%
Net Income Growth Years	0%
Net Income Growth3 Y	-12.9%
Net Income Growth5 Y	-20.33%
Pretax Margin	25.49%
Profit Margin	20.11%
Profit Per Employee	SGD 20,422
Profitable Years	21
Roa5y	18.2
Roe5y	27.11
ROIC	22.77
Roic5y	62.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.69%
Cagr15y	20.76%
Cagr1y	-9.74%
Cagr3y	17.95%
Cagr5y	0.52%
Div CAGR10	15.03%
Div CAGR3	-24.31%
Div CAGR5	-8.9%
EPS Growth	-27.59
EPS Growth Q	-23.04
EPS Growth Years	0
EPS Growth3 Y	-12.89
EPS Growth5 Y	-20.33
FCF Growth	-2.04%
FCF Growth Q	75.1%
FCF Growth3 Y	-3.16%
FCF Growth5 Y	-18.29%
OCF Growth	-0.23%
OCF Growth Q	63.89%
OCF Growth10 Y	9.63%
OCF Growth3 Y	-6.8%
OCF Growth5 Y	-15.3%
Revenue Growth	-7.23x
Revenue Growth Q	-9.82x
Revenue Growth Years	0x
Revenue Growth3 Y	-7.55x
Revenue Growth5 Y	-11.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	SGD 201M
Current Assets	SGD 287.1M
Current Liabilities	SGD 31.1M
Equity	SGD 469.7M
Interest Coverage	11,210.3
Net Cash	SGD 201M
Net Cash By Market Cap	SGD 17.73
Net Cash Growth	-11.76%
Net Debt EBITDA	SGD -2.14
Net Debt Equity	SGD -0.43
Tangible Book Value	SGD 469.7M
Tangible Book Value Per Share	SGD 0.32
WACC	8.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Working Capital Turnover	SGD 0.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-35.59%
Dividend Growth Years	0%
Dividend per share	SGD 0.05
Dividend Years	20
Dividend Yield	7.18%
Ex Div Date	2026-05-07
Last Dividend	SGD 0.02
Payout Frequency	Quarterly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	230.2%
1Y total return	-9.73%
200-day SMA	0.79
3Y total return	64.12%
50-day SMA	0.74
50-day SMA vs 200-day SMA	50under200
5Y total return	2.6%
All Time High	2.45
All Time High Change	-68.78%
All Time High Date	2020-08-07
All Time Low	0.07
All Time Low Change	1,053.85%
All Time Low Date	2006-11-28
ATR	0.02
Beta	0.75
Beta1y	0.54
Beta2y	0.27
Ch YTD	-12.07
High	0.77
High52	0.92
High52 Date	2026-01-22
High52ch	-18.62%
Low	0.73
Low52	0.64
Low52 Date	2025-06-23
Low52ch	20.47%
Ma50ch	4.05%
Price vs 200-day SMA	-2.61%
RSI	56.25
RSI Monthly	47.77
RSI Weekly	47.65
Sharpe ratio	0.26x
Sortino ratio	0.58
Total Return	7.18%
Tr YTD	-8.48
Tr15y	1,593.27%
Tr1m	11.73%
Tr1w	3.59%
Tr3m	6.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SGD 71.4M
Operating Income Growth	-26.26
Operating Income Growth Q	-14.74
Operating Income Growth3 Y	-14.7
Operating Income Growth5 Y	-21.93
Operating margin	23.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	520,871,660%
Net Borrowing	-155,463.2
Shares Insiders	64.39%
Shares Institutions	13.7%
Shares Out	1,482,168,100
Shares Qo Q	0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,211,155x
Bv Per Share	0.32
Ch10y	62.77
Ch15y	587.3
Ch1m	9.29
Ch1w	1.33
Ch1y	-18.18
Ch3m	2
Ch3y	28.57
Ch5y	-42.48
Ch6m	-12.07
Change	4.79%
Change From Open	4.79
Close	0.73
Days Gap	0
Depreciation Amortization	23,100,671.5
Dollar Volume	5,110,965
Earnings Date	2026-05-14
EBIT	SGD 71.4M
EBITDA	SGD 94M
EPS	SGD 0.04
F Score	1
Fiscal Year End	December
Founded	1,989
Graham Number	0.54292
Graham Upside	-29.03
Income Tax	SGD 16.4M
Is Primary Listing	1
Last Earnings Date	2026-02-23
Last Report Date	2025-12-31
Last Split Date	2020-11-09
Last Split Type	Forward
Lynch Fair Value	SGD 0.21
Lynch Upside	-72.98
Ma150	0.8
Ma150ch	-4.89%
Ma20	0.76
Ma20ch	0.99%
Next Earnings Date	2026-05-14
Open	0.73
Payment Date	2026-05-15
Position In Range	88.89
Ppne	242,593,088.3
Price Date	2026-05-08
Price EBITDA	SGD 12.06
Ptbv Ratio	2.41
Relative Volume	2.08x
Revenue	304,728,012x
Tax By Revenue	5.38x
Tax Rate	21.11%
Tr6m	-7.61%
Volume	6,681,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SGX/AP4 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.2%

$0.05 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-8.9%

0 consecutive years of growth

Total shareholder yield

+7.2%

Next ex-dividend date: 2026-05-07

Performance

SGX/AP4 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SGX/AP4?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.7%

Share of float held by funds and institutions

Insider ownership

+64.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

SGX/AP4 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.3

Neutral momentum band

Price vs 200-day MA

-2.6%

50/200-day relationship not available

Beta (5Y)

0.75

Less volatile than the market

Sharpe ratio

0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SGX/AP4

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sgx/AP4 stock rating?

sgx/AP4 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sgx/AP4 analysis?

The full report lives at /stocks/sgx/AP4/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sgx/AP4?

The latest report frames sgx/AP4 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sgx/AP4 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.